NCT05596344 Long-term Follow-up of Anxiety and Depression in Patients With Malignant Tumors
| NCT ID | NCT05596344 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Henan Cancer Hospital |
| Condition | Malignant Tumor |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2023-05-20 |
| Primary Completion | 2032-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2023-05-20 with a primary completion date of 2032-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study was a single-center prospective, real-world observational study with plans to enroll all eligible patients. The basic information, anxiety and depression, treatment and prognosis of these patients were collected.
Eligibility Criteria
Inclusion Criteria: 1. Men and women of all ages are welcome. 2. Pathological diagnosis of malignant tumor in our hospital. 3. Received at least one hospitalization at this hospital. 4. The expected survival time is greater than 1 year. Exclusion Criteria: 1.There was no pathological report of malignancy.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05596344 clinical trial?
This trial is open to participants of all sexes, studying Malignant Tumor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05596344 currently recruiting?
Yes, NCT05596344 is actively recruiting participants. Contact the research team at wjqwtj@126.com for enrollment information.
Where is the NCT05596344 trial being conducted?
This trial is being conducted at Zhengzhou, China.
Who is sponsoring the NCT05596344 clinical trial?
NCT05596344 is sponsored by Henan Cancer Hospital. The trial plans to enroll 200 participants.